GABA and benzodiazepine receptors in basal ganglia function
dc.contributor.author | Young, Anne B. | en_US |
dc.contributor.author | Pan, Helen S. | en_US |
dc.contributor.author | Ciliax, Brian J. | en_US |
dc.contributor.author | Penney, John B. | en_US |
dc.date.accessioned | 2006-04-07T18:26:27Z | |
dc.date.available | 2006-04-07T18:26:27Z | |
dc.date.issued | 1984-06-29 | en_US |
dc.identifier.citation | Young, Anne B., Pan, Helen S., Ciliax, Brian J., Penney, John B. (1984/06/29)."GABA and benzodiazepine receptors in basal ganglia function." Neuroscience Letters 47(3): 361-367. <http://hdl.handle.net/2027.42/24774> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T0G-482RJ1R-1N/2/b4b45fc1597ea919563de07783668fdd | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24774 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6089057&dopt=citation | en_US |
dc.description.abstract | GABA and its associated benzodiazepine interactions play an important role in basal ganglia function. Distinctive GABA, benzodiazepine and opiate receptor changes occur in response to striatal lesions and in the human neurodegenerative disorder, Huntington's disease (HD). In animal experiments, the in vivo administration of [3H]flunitrazepam labels benzodiazepine receptors and can demonstrate the receptor changes seen after striatal lesions. It should be possible to measure these receptors in vivo in humans using positron-emission tomographic scanning. | en_US |
dc.format.extent | 400607 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | GABA and benzodiazepine receptors in basal ganglia function | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Psychology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbtoplevel | Social Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A. | en_US |
dc.identifier.pmid | 6089057 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24774/1/0000198.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0304-3940(84)90540-8 | en_US |
dc.identifier.source | Neuroscience Letters | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.